Paper9536271
Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase.
Friedlos F and 4 others. Gene Ther, 1998. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase. Papers, record 9536271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9536271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene-directed enzyme prodrug therapy: quantitative bystander cytotoxicity and DNA damage induced by CB1954 in cells expressing bacterial nitroreductase.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aziridines | Major topic |
| DNA Damage | Major topic |
| Genetic Therapy | Major topic |
| Neoplasms | Major topic |
| Nitroreductases | Major topic |
| Escherichia coli | |
| Gene Expression | |
| Humans | |
| Prodrugs | |
| Transfection | |
| Tumor Cells, Cultured |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883232 | Chemical Constructions, Mechanism and Biological Interpretation of Nitroreductase-Responsive Systems: From Hypoxia-Associated Imaging to Activatable Therapy. | Molecules | 2026 | https://conductscience.org/library/papers/42883232 | PubMed |
| 26613930 | An overview of targeted cancer therapy. | Biomedicine (Taipei) | 2015 | https://conductscience.org/library/papers/26613930 | PubMed |
| 25772134 | Engineering Stem Cells for Biomedical Applications. | Adv Healthc Mater | 2016 | https://conductscience.org/library/papers/25772134 | PubMed |
| 24428354 | Enhanced cell-specific ablation in zebrafish using a triple mutant of Escherichia coli nitroreductase. | Zebrafish | 2014 | https://conductscience.org/library/papers/24428354 | PubMed |
| 17975564 | The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR). | Cancer Gene Ther | 2007 | https://conductscience.org/library/papers/17975564 | PubMed |
| 16046682 | Japanese spousal smoking study revisited: how a tobacco industry funded paper reached erroneous conclusions. | Tob Control | 2005 | https://conductscience.org/library/papers/16046682 | PubMed |
| 14997211 | 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT. | Br J Cancer | 2004 | https://conductscience.org/library/papers/14997211 | PubMed |
| 12686722 | Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy). | J Biomed Biotechnol | 2003 | https://conductscience.org/library/papers/12686722 | PubMed |
| 11922390 | Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy. | Neoplasia | 2002 | https://conductscience.org/library/papers/11922390 | PubMed |
| 11122820 | Prodrug/drug sensitivity gene therapy: current status. | Curr Oncol Rep | 2000 | https://conductscience.org/library/papers/11122820 | PubMed |
| 10791987 | Prodrug-activating systems in suicide gene therapy. | J Clin Invest | 2000 | https://conductscience.org/library/papers/10791987 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9536271
GET https://conductscience.org/api/papers/v1/9536271/authors